Target Name: PKP3
NCBI ID: G11187
Review Report on PKP3 Target / Biomarker Content of Review Report on PKP3 Target / Biomarker
PKP3
Other Name(s): plakophilin 3b | Plakophilin 3, transcript variant 1 | Plakophilin-3 | PKP3 variant 1 | plakophilin 3 | PKP3_HUMAN

PKP3: An Anterograde Transporter of Diacylglycerol

PKP3 (Plakophilin 3b) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and muscles. It is a member of the family of phospholipid transporters, which are responsible for transporting phospholipids across cell membranes. PKP3 is characterized by its ability to transport diacylglycerol (DAG) across cell membranes, which is a key component of cell signaling.

DAG is a critical signaling molecule that plays a role in various cellular processes, including cell signaling, protein synthesis, and intracellular transport. It is often used as a drug target or biomarker because of its unique structure and the role it plays in various biological processes.

One of the unique features of PKP3 is its ability to transport DAG across cell membranes in a specific direction, which is crucial for its function. PKP3 is an anterograde transporter, which means that it transports DAG from the intracellular space to the cell membrane in the direction of the arrow. This is important for the regulation of cellular signaling because DAG is often used as a signaling molecule in cell signaling pathways.

PKP3 is also involved in the regulation of protein synthesis and translation. It has been shown to play a role in the regulation of protein synthesis by affecting the levels of intracellular DAG. Additionally, PKP3 has been shown to regulate protein translation by affecting the levels of DAG in the cytoplasm.

In addition to its role in protein synthesis and translation, PKP3 is also involved in the regulation of cell signaling. It has been shown to play a role in the regulation of cellular signaling by affecting the levels of DAG in the cytoplasm. Additionally, PKP3 has been shown to interact with various signaling molecules, including TOR, which is a well-known protein that regulates cellular signaling pathways.

PKP3 is also involved in the regulation of cell adhesion. It has been shown to play a role in the regulation of cell adhesion by affecting the levels of DAG in the cytoplasm. Additionally, PKP3 has been shown to interact with various adhesion molecules, including cadherin, which is a well-known protein that regulates cell adhesion.

In conclusion, PKP3 is a protein that is involved in various cellular processes, including cell signaling, protein synthesis, and cell adhesion. Its unique structure and the role it plays in these processes make it an attractive drug target or biomarker. Further research is needed to fully understand the role of PKP3 in these processes and its potential as a drug.

Protein Name: Plakophilin 3

Functions: May play a role in junctional plaques

The "PKP3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PKP3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PKP4 | PKP4-AS1 | PLA1A | PLA2G10 | PLA2G12A | PLA2G12AP1 | PLA2G12B | PLA2G15 | PLA2G1B | PLA2G2A | PLA2G2C | PLA2G2D | PLA2G2E | PLA2G2F | PLA2G3 | PLA2G4A | PLA2G4B | PLA2G4C | PLA2G4D | PLA2G4E | PLA2G4F | PLA2G5 | PLA2G6 | PLA2G7 | PLA2R1 | PLAA | PLAAT1 | PLAAT2 | PLAAT3 | PLAAT4 | PLAAT5 | PLAC1 | PLAC4 | PLAC8 | PLAC8L1 | PLAC9 | PLAC9P1 | PLAG1 | PLAGL1 | PLAGL2 | Plasma Membrane Calcium ATPase | PLAT | Platelet Glycoprotein Ib Complex | Platelet-activating factor acetylhydrolase isoform 1B complex | Platelet-Derived Growth Factor (PDGF) | Platelet-Derived Growth Factor Receptor | PLAU | PLAUR | PLB1 | PLBD1 | PLBD1-AS1 | PLBD2 | PLCB1 | PLCB2 | PLCB3 | PLCB4 | PLCD1 | PLCD3 | PLCD4 | PLCE1 | PLCE1-AS2 | PLCG1 | PLCG1-AS1 | PLCG2 | PLCH1 | PLCH2 | PLCL1 | PLCL2 | PLCXD1 | PLCXD2 | PLCXD3 | PLCZ1 | PLD1 | PLD2 | PLD3 | PLD4 | PLD5 | PLD6 | PLEC | PLEK | PLEK2 | PLEKHA1 | PLEKHA2 | PLEKHA3 | PLEKHA4 | PLEKHA5 | PLEKHA6 | PLEKHA7 | PLEKHA8 | PLEKHA8P1 | PLEKHB1 | PLEKHB2 | PLEKHD1 | PLEKHF1 | PLEKHF2 | PLEKHG1 | PLEKHG2 | PLEKHG3 | PLEKHG4 | PLEKHG4B